Latest Conference Articles

Dr. John Kulig commented on news stories about parents who have taken it upon themselves to administer medical marijuana to their children without consulting a physician.

Mark Wolraich, MD, FAAP, lead author, discussed the updated ADHD guidelines which now include information on the diagnosis and treatment of children and adolescents.

Eric Kossoff, MD, started off the session "First and Second Seizure…Now What Do I Do?" saying how important it is as physicians to calm parents down when their child experiences a seizure.

One of the first sessions on Day 2 in Boston featured Kathryn Ellerbeck, MD, FAAP, and Catherine Smith, PhD talking about the difficulties in diagnosing children with autism.

At the end of this morning's AAP session on autism, attendees were able to ask questions and presenters provided resources to prepare them for diagnostic changes.

Dr. Marion Burton, AAP President, started his address by talking about a YouTube video that had gone viral featuring a little boy who excitedly proclaimed, "I feel happy of myself!" The message of this video was featured throughout Burton's discussion.

Keynote speaker Caroll Spinney, the puppeteer who plays Big Bird and Oscar the Grouch on the famous children's TV show Sesame Street, spoke this morning about the importance of compassion.

Less than half of pediatric car passengers suffering injuries from motor vehicle crashes were restrained, with the lowest rates among blacks, Hispanics and Native Americans, according to a research abstract presented at AAP 2011.

Here is information about some of the topics that are being discussed at this year's IDSA Annual Meeting.

Stay tuned for live coverage from the conference starting October 15.

David Sacks, MD talks about the American diabetes association meeting.

More patients in the RIDE and RISE trials treated with the VEGF inhibitor showed improvements in vision test scores compared to patients who received placebo.

Treatment with metformin and diet and lifestyle modifications both are cost-effective means of decreasing diabetes risk and improving quality of life.

Researchers are investigating novel ways to preserve beta cell function in type 1 diabetes patients and enhance the body's ability to produce its own insulin.

Researchers are investigating a variety of targets and pathways in the search for an effective weight-loss drug.

Structured self-monitoring of blood glucose may result in lower levels of a key marker of cardiovascular disease risk in patient with type 2 diabetes.

Nonadherent patients with diabetes face severely increased risks of hospitalization and death.

Patients treated with sensor-augmented pump therapy may achieve lower glycemic variability than patients given multiple daily insulin injections.

Real-time blood sugar and insulin infusion data displayed in the electronic medical record allows physicians to tailor treatment and get more patients to goal.

LEAD-6 trial results show improved glycemic control with weight loss and a low risk of hypoglycemia with liraglutide and exenatide.

New program utilizes mobile technology to improve diabetes prevention and management.

Japanese trial of TS-071 shows promise in weight loss and HbA1c reduction.

There are several challenges to effective diabetes care that are specific to geriatric patients.

Access information about how to follow the conference through social media and some of the key sessions worth checking out.

Dr. Trevor Orchard previews what he will be discussing during his presentation on cardiovascular disease in patients with type 1 diabetes at the ADA meeting.

Dr. Suzanne Boren previews what she will be discussing during her presentation on the cost effectiveness of diabetes education at ADA 2011.

Dr. Ann Albright previews what she will be discussing during her presentation on national diabetes prevention at the upcoming ADA annual meeting.

Intestinal decontamination with rifaximin prevents spontaneous bacterial peritonitis and improves transplant-free survival in cirrhotic patients with ascites.

Cardiovascular risks associated with discontinuing clopidogrel before elective colonoscopy exceed the risks of post-polypectomy bleeding.

GLP-2 analog teduglutide reduces the need for parenteral support in patients with short bowel syndrome-intestinal failure.